Average Insider

Where insiders trade, we follow

Hemab Therapeutics Holdings, Inc.

๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
$COAG
$26.45
Current Price
N/A
Market Cap
52W Low$23.00
Current$26.4525.3% above low, 74.7% below high
52W High$36.61

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys12$1,689,818.4867,669All Buys
Sells00--
2 weeksBuys12$1,689,818.4867,669All Buys
Sells00--
1 monthBuys12$1,689,818.4867,669All Buys
Sells00--
2 monthsBuys116$55,460,170.872,970,541All Buys
Sells00--
3 monthsBuys116$55,460,170.872,970,541All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jun 16, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase61,523$24.98$1,536,844.54View Details
Jun 15, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase6,146$24.89$152,973.94View Details
May 19, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase3,802$24.97$94,935.94View Details
May 20, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase996$24.94$24,840.24View Details
May 12, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase6,387$24.90$159,036.30View Details
May 7, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase1,985$24.95$49,525.75View Details
May 11, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase14,149$24.47$346,226.03View Details
May 8, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase1,483$24.98$37,045.34View Details
May 11, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase25,720$25.00$643,000.00View Details
May 7, 2026
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Purchase7,921$24.34$192,797.14View Details
May 4, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Purchase133,750$18.00$2,407,500.00View Details
May 5, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Purchase87,143$24.59$2,142,846.37View Details
May 5, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Purchase10,268$25.00$256,700.00View Details
May 6, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Purchase53,407$24.83$1,326,095.81View Details
May 6, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Purchase14,611$23.77$347,303.47View Details
May 4, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Purchase2,541,250$18.00$45,742,500.00View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No past earnings data available

Related Activity

Cross-company insider connections and cluster buy signals

Insiders Also Active At

Insiders at this company also hold positions or have traded at these companies:

$CDTX โ€” Cidara Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$WVE โ€” Wave Life Sciences Ltd.via RA CAPITAL MANAGEMENT, L.P.$PBLS โ€” Parabilis Medicines, Inc.via RA CAPITAL MANAGEMENT, L.P.$ACET โ€” Adicet Bio, Inc.via RA CAPITAL MANAGEMENT, L.P.$CLYM โ€” Climb Bio, Inc.via RA CAPITAL MANAGEMENT, L.P.$SGP โ€” SpyGlass Pharma, Inc. Common Stockvia RA CAPITAL MANAGEMENT, L.P.$ETNB โ€” 89bio, Inc.via RA CAPITAL MANAGEMENT, L.P.$HOWL โ€” Werewolf Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$ARTV โ€” Artiva Biotherapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$JANX โ€” Janux Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.
Version: v26.5.2